Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Dr. Reddy's Laboratories Limited | Medchal-Malkajgiri, India | Makes it and tests it | Problems found, fixed voluntarilyOct 27, 2023 · 8 inspections |
Recalls
- Mar 6, 2017 · Class III · Dr. Reddy's Laboratories, Inc.
Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.
Lots: Lot #C607323, Exp 10/18 - Aug 3, 2015 · Class II · Dr. Reddy's Laboratories, Inc.
Failed Dissolution Specifications
Lots: Lot #: C501342; Exp 01/2017
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Rivastigmine: every company that makes it
- Form
- capsule, oral
- Strength
- 1.5 mg
- Approval
- ANDA ANDA077130
- On the market since
- Sep 1, 2011
- Package NDCs
55111-352-0155111-352-0555111-352-3055111-352-60- Official label
- DailyMed (National Library of Medicine), updated Jan 23, 2019
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?